SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs > Advaxis, Inc. (ADXS)

Terry, I'm glad you brought this up.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Gantor50 Member Profile
Member Level 
Followed By 49
Posts 1,478
Boards Moderated 0
Alias Born 01/13/14
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 12/4/2017 4:35:17 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 12/4/2017 4:31:53 PM
Quotidian Technical Highlights on Selected Biotech Stocks -- Advaxis, Grifols, Juno Therapeutics, and Lexicon Pharma "PR Newswire (US)" - 11/27/2017 7:05:00 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 11/9/2017 5:25:39 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/6/2017 6:02:21 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/6/2017 6:02:21 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/6/2017 6:02:21 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/6/2017 6:02:21 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/6/2017 6:02:21 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/6/2017 6:01:53 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/6/2017 6:01:53 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/6/2017 6:01:53 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/6/2017 6:01:53 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/6/2017 6:01:26 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/2/2017 6:02:03 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/2/2017 5:56:10 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/2/2017 5:52:50 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/12/2017 3:55:36 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/2/2017 4:31:51 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/2/2017 4:31:51 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 9/27/2017 8:51:46 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/26/2017 5:26:54 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/25/2017 4:55:48 PM
Biotech's Recently Under the Microscope, Analyst Coverage "InvestorsHub NewsWire" - 9/20/2017 8:00:00 AM
Advaxis to Present at Cantor Fitzgerald Global Healthcare Conference "Business Wire" - 9/18/2017 9:02:00 AM
Gantor50 Member Level  Friday, 10/06/17 12:06:08 PM
Re: A deleted message
Post # of 45941 
Terry, I'm glad you brought this up. I have read you make this point over the years, and I glady cede to you when it comes to the history of ADXS.

Let's assume you are 100% correct about HER2. My question is even if that was true, based on your opinion, do you see enough benefits in HER2 to outweigh the risks? For example, say a Doctor told me he might be able to save my life and eliminate my particular cancer with a HER2 construct. But he also warned me that approx. 5 out of 100 people who take the drug he is going to give me will die from a heart attack, and asked me what I want to do.

In other words, do you think HER2 would be viable with a (hypothetical) black box label? A number of drugs have been very successful even after a black box label because patients determined that the potential benefits outweighed the potential risks.


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist